BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10706878)

  • 1. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.
    Falini B; Fizzotti M; Pucciarini A; Bigerna B; Marafioti T; Gambacorta M; Pacini R; Alunni C; Natali-Tanci L; Ugolini B; Sebastiani C; Cattoretti G; Pileri S; Dalla-Favera R; Stein H
    Blood; 2000 Mar; 95(6):2084-92. PubMed ID: 10706878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programming plasma cell survival.
    Klein U
    J Exp Med; 2014 May; 211(5):744. PubMed ID: 24799529
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma in dogs: Use of the cell block technique as a new diagnostic tool.
    Valente PCLG; Peleteiro MC; Dias MJ; Vicente G; Pomba C; Duarte A; Correia J
    Vet Clin Pathol; 2024 Mar; 53(1):93-98. PubMed ID: 38240087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis.
    Katsarou A; Trasanidis N; Ponnusamy K; Kostopoulos IV; Alvarez-Benayas J; Papaleonidopoulou F; Keren K; Sabbattini PMR; Feldhahn N; Papaioannou M; Hatjiharissi E; Sudbery IM; Chaidos A; Caputo VS; Karadimitris A
    Blood Adv; 2023 Nov; 7(21):6395-6410. PubMed ID: 37224458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
    Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
    Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUM1/IRF4: A Review.
    Gualco G; Weiss LM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):301-10. PubMed ID: 20182347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4.
    Valsami S; Pappa V; Rontogianni D; Kontsioti F; Papageorgiou E; Dervenoulas J; Karmiris T; Papageorgiou S; Harhalakis N; Xiros N; Nikiforakis E; Economopoulos T
    Haematologica; 2007 Oct; 92(10):1343-50. PubMed ID: 17768115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.
    Natkunam Y; Warnke RA; Montgomery K; Falini B; van De Rijn M
    Mod Pathol; 2001 Jul; 14(7):686-94. PubMed ID: 11455001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.
    Zhou L; Gu B; Shen X; Binshen O; Dong L; Zhou J; Yi H; Wang C
    Pathol Int; 2021 Mar; 71(3):183-190. PubMed ID: 33503299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
    Ramis-Zaldivar JE; Gonzalez-Farré B; Balagué O; Celis V; Nadeu F; Salmerón-Villalobos J; Andrés M; Martin-Guerrero I; Garrido-Pontnou M; Gaafar A; Suñol M; Bárcena C; Garcia-Bragado F; Andión M; Azorín D; Astigarraga I; Sagaseta de Ilurdoz M; Sábado C; Gallego S; Verdú-Amorós J; Fernandez-Delgado R; Perez V; Tapia G; Mozos A; Torrent M; Solano-Páez P; Rivas-Delgado A; Dlouhy I; Clot G; Enjuanes A; López-Guillermo A; Galera P; Oberley MJ; Maguire A; Ramsower C; Rimsza LM; Quintanilla-Martinez L; Jaffe ES; Campo E; Salaverria I
    Blood; 2020 Jan; 135(4):274-286. PubMed ID: 31738823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
    Salaverria I; Philipp C; Oschlies I; Kohler CW; Kreuz M; Szczepanowski M; Burkhardt B; Trautmann H; Gesk S; Andrusiewicz M; Berger H; Fey M; Harder L; Hasenclever D; Hummel M; Loeffler M; Mahn F; Martin-Guerrero I; Pellissery S; Pott C; Pfreundschuh M; Reiter A; Richter J; Rosolowski M; Schwaenen C; Stein H; Trümper L; Wessendorf S; Spang R; Küppers R; Klapper W; Siebert R; ; ;
    Blood; 2011 Jul; 118(1):139-47. PubMed ID: 21487109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine.
    Tawfik A; Kawaguchi T; Takahashi M; Setoh K; Yamaguchi I; Tabara Y; Van Steen K; Sakuntabhai A; Matsuda F
    Vaccines (Basel); 2024 Jan; 12(2):. PubMed ID: 38400120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
    Bibas M
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional reprogramming by mutated IRF4 in lymphoma.
    Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
    Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal composition and differentiation stage of human CD30
    Küppers R; Budeus B; Hartmann S; Hansmann ML
    Front Immunol; 2023; 14():1208610. PubMed ID: 37559724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
    Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
    Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Detection of EBV and Human Polyomavirus JCPyV in a Case of AIDS-Related Multifocal Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
    Barbier MT; Del Valle L
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
    Falini B; Martino G; Lazzi S
    Leukemia; 2023 Jan; 37(1):18-34. PubMed ID: 36460764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.